Unterehmen auf Watchlist setzen
Worldwide Healthcare
ISIN: GB00BN455J50
WKN: A3EJG1
Über
Unternehmensprofil
Tipp: Investor-Alerts aktivieren
Lassen Sie sich bei neuen Publikationen informieren
Tipp: AI-Factsheet

Corporate News meets AI! 
Analyse der Inhalte und Zusammenfassung

Worldwide Healthcare · ISIN: GB00BN455J50 · PR Newswire (ID: 202411260118)
26 November 2024 06:30PM

Worldwide Healthcare Trust PLC - Transaction in Own Shares


For immediate release

26 November 2024

 

 

WORLDWIDE HEALTHCARE TRUST PLC

(the "Company")

 

 

MARKET PURCHASE OF COMPANY'S OWN SHARES

 

 

 

This notification is given, pursuant to the authority granted at an Annual General Meeting of the Company held on 10 July 2024 to make market purchases of the Company's own shares up to an aggregate maximum of 79,248,688.

 

The Company has purchased a market total of 297,246 Ordinary shares of 2.5p each in the capital of the Company today at a price of 327.10 pence per share. These shares will be held in treasury.

 

Following this transaction, the Company hereby notifies the market that the resultant number of Ordinary shares held by the Company in treasury is 89,995,650 and the total number of Ordinary shares that the Company has in issue is 601,665,200 so that the total number of voting rights in the Company following the repurchase is 511,669,550.

 

The figure of 511,669,550 may be used by shareholders as the denominator for the calculation by which they may determine if they are required to notify their interest in, or change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

 

 

For and on behalf of

Frostrow Capital LLP

Company Secretary

 

For further information, please contact:

 

Mark Pope

Frostrow Capital LLP

Tel: 020 3 0084913

 





Visuelle Wertentwicklung / Kursverlauf · Worldwide Healthcare
Smarte Analyse- und Recherchewerkzeuge finden Sie hier.
This publication was provided by our content partner PR Newswire
PR Newswire
via PR Newswire - Newsfeed
Cision ©2024
PR Newswire
Kontakt:
300 S Riverside Plaza, Chicago, Illinois, USA
+001 (0) 888-776-0942